News

FDA approves alirocumab, first injectable lipid-lowering biologic therapy

Publish date: July 24, 2015

 

FROM THE FDA

References

The prescribing information is available at http://1.usa.gov/1KpIU82.

emechcatie@frontlinemedcom.com

Pages

Recommended Reading

VIDEO: EULAR updates cardiovascular-disease risk recommendations
MDedge Internal Medicine
Cognitive impairment signals subclinical vascular disease
MDedge Internal Medicine
WCD: Psoriasis plus depression magnifies MI risk
MDedge Internal Medicine
ADA: DPP4 inhibitors and cardiovascular outcomes: connecting the dots
MDedge Internal Medicine
EULAR: Panel previews updated CVD recommendations
MDedge Internal Medicine
Half of Hispanics unaware of their high cholesterol
MDedge Internal Medicine
Rosacea linked to dyslipidemia, hypertension, CAD
MDedge Internal Medicine
Study quantifies risks linked to cardiac multimorbidity
MDedge Internal Medicine
FDA will strengthen heart attack, stroke risk warnings for all NSAIDs
MDedge Internal Medicine
ACC/AHA cholesterol guideline found efficient, cost effective
MDedge Internal Medicine

Related Articles